NOS3 and breast cancer: In fact, we have demonstrated that the stimulation of endothelial cells with different agonists secreted by tumor cells and elevated in serum of breast cancer patients activate eNOS and the S-nitrosylation pathway in the endothelium resulting in loss of endothelial integrity [20, 42, 82].